Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Editas Medicine (EDIT)

Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Editas: Q3 Earnings Snapshot AP - Mon Nov 4, 6:36AM CST

Editas: Q3 Earnings Snapshot

EDIT : 2.88 (-1.03%)
Editas Medicine Announces Third Quarter 2024 Results and Business Updates GlobeNewswire - Mon Nov 4, 6:30AM CST

EDIT : 2.88 (-1.03%)
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and Strategic Update GlobeNewswire - Tue Oct 22, 6:00AM CDT

EDIT : 2.88 (-1.03%)
Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics GlobeNewswire - Mon Oct 21, 3:30PM CDT

EDIT : 2.88 (-1.03%)
Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept GlobeNewswire - Fri Oct 18, 3:01PM CDT

EDIT : 2.88 (-1.03%)
Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust GlobeNewswire - Thu Oct 3, 5:00PM CDT

EDIT : 2.88 (-1.03%)
Looking for Stock Bargains With Room to Run? Try This. Motley Fool - Wed Sep 11, 3:07PM CDT

Investing tips from Bill Mann, The Motley Fool's director of small-cap research.

WBA : 9.33 (-1.37%)
AAPL : 222.01 (-0.40%)
AMZN : 195.78 (-1.09%)
EXPE : 161.11 (+1.07%)
DENN : 6.57 (+0.92%)
CBRL : 45.85 (-2.41%)
JACK : 50.10 (-0.54%)
BJRI : 33.44 (-1.62%)
SABR : 3.22 (+1.26%)
EDIT : 2.88 (-1.03%)
CRSP : 50.59 (-0.33%)
DESP : 14.31 (-1.72%)
Editas: Q2 Earnings Snapshot AP - Wed Aug 7, 6:07AM CDT

Editas: Q2 Earnings Snapshot

EDIT : 2.88 (-1.03%)
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5? Motley Fool - Thu May 9, 12:12PM CDT

The company has great potential if and when it enters the commercial stage.

C : 62.35 (-2.13%)
EDIT : 2.88 (-1.03%)
Editas: Q1 Earnings Snapshot AP - Wed May 8, 6:29AM CDT

Editas: Q1 Earnings Snapshot

EDIT : 2.88 (-1.03%)

Barchart Exclusives

What the Election Results May Mean for the Corn and Soybean Markets Barchart - Mon Nov 4, 2:00PM CST
Taking a look at whether the trade war comes back and what it means if it does. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot